Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Liposomal Bupivacaine TAP Block Plus Pain Control to Help Gut Recovery After Major Abdominal Surgery

Official title: Effect of Liposomal Bupivacaine TAPB Combined With Oxycodone PCIA on Postoperative Gastrointestinal Function in Patients Undergoing Major Abdominal Surgery: A Randomized Controlled Trial

Run by Tianjin First Central Hospital · NCT07651722 · Data updated 2026-11-12

This trial tests whether adding liposomal bupivacaine TAP block to a sufentanil or oxycodone-based pain plan helps people recover gut function after major abdominal surgery.

More Postoperative Pain trials

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment132 (estimated)
SponsorTianjin First Central Hospital
Academic / other
Locations1 site (Tianjin, Tianjin Municipality)
StatusRecruiting
StartedJune 16, 2026
Main results expectedSeptember 2026
Study endsSeptember 2026
Registry record updatedJune 25, 2026
Trial IDNCT07651722 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18-80 undergoing elective small bowel or colorectal surgery, ASA I-III, able to consent and comply with postoperative assessments.

Probably not a fit

Patients with certain comorbidities, drug sensitivities, or those not benefiting from regional analgesia may see no GI recovery improvement.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, randomized, double-blind study enrolling adults 18-80 with ASA I-III undergoing elective small bowel or colorectal surgery. Participants are assigned to three postoperative analgesia regimens: R-S (ropivacaine TAP block with sufentanil PCIA), LB-S (liposomal bupivacaine TAP block with sufentanil PCIA), or LB-O (liposomal bupivacaine TAP block with oxycodone PCIA). The primary outcome is the AUC of the I-FEED score, a measure of postoperative gastrointestinal recovery. The trial aims to determine if the liposomal bupivacaine TAP block improves GI recovery and safety compared with standard regimens. Eligible patients must consent and comply with assessments; several medical exclusions apply.

Why it matters

Potential benefit: If successful, the regimen could shorten GI recovery time and improve comfort after major abdominal surgery.

How similar studies have gone: Previous regional analgesia studies suggest potential GI recovery benefits, but the specific liposomal TAP block approach with this regimen is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients scheduled to undergo elective major abdominal surgery, specifically small bowel or colorectal resections.
* Aged between 18 and 80 years (inclusive).
* American Society of Anesthesiologists (ASA) physical status I, II, or III.
* Capable of understanding the study procedures, cooperating with postoperative pain/recovery assessments (e.g., VAS, QoR-15, I-FEED), and providing written informed consent prior to surgery.

Exclusion Criteria:

* History of significant neuropsychiatric disorders, including schizophrenia, epilepsy, Parkinson's disease, or myasthenia gravis, that may interfere with pain perception or cognitive evaluation.
* History of alcohol abuse or chronic opioid/analgesic dependence.
* Severe, uncontrolled hypertension (defined as systolic blood pressure ≥ 180 mmHg or diastolic blood pressure ≥ 110 mmHg).
* Severe cardiac, hepatic, renal, or pulmonary dysfunction that poses a high surgical/anesthetic risk or alters drug metabolism.
* Pregnant or lactating women.
* Known allergy, hypersensitivity, or contraindications to any of the study medications, including local anesthetics (ropivacaine, bupivacaine) or opioids (sufentanil, oxycodone).

Where it's running

  • Tianjin First Central Hospital
    Tianjin, Tianjin Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.